Cholecystokinin receptors do not mediate the behavioral effects of lipopolysaccharide in mice

被引:13
作者
Bluthe, RM [1 ]
Michaud, B [1 ]
Kelley, KW [1 ]
Dantzer, R [1 ]
机构
[1] UNIV ILLINOIS, IMMUNOPHYSIOL LAB, URBANA, IL 61801 USA
基金
美国国家卫生研究院;
关键词
lipopolysaccharide; cholecystokinin (CCK); CCK-A receptors; CCK-B receptors; social exploration; sickness; behavior; mice;
D O I
10.1016/S0031-9384(97)00035-8
中图分类号
B84 [心理学];
学科分类号
04 [教育学]; 0402 [心理学];
摘要
To test the possible role of cholecystokinin (CCK) in the decrease of social exploration induced by intraperitoneal (IP) injection of lipopolysaccharide (LPS, 100 mu g/kg), mice were pretreated with IP or intracerebroventricular (ICV) injection of the CCKA receptor antagonist L-364,718 (3 mg/kg and 10 mu g/kg, respectively) and the CCKB receptor antagonist L-365,260 (1 mg/kg and 10 mu g/kg, respectively). L-364,718 and L-365,260 did not alter LPS-induced decrease in social investigation, whatever the route of administration, suggesting that endogenous cholecystokinin does not mediate the effect of proinflammatory cytokines on social exploration in mice. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:385 / 389
页数:5
相关论文
共 51 条
[1]
Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally [J].
Bluthe, RM ;
Michaud, B ;
Kelley, KW ;
Dantzer, R .
NEUROREPORT, 1996, 7 (09) :1485-1488
[2]
BLUTHE RM, 1994, CR ACAD SCI III-VIE, V317, P499
[3]
Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes [J].
Bluthe, RM ;
Michaud, B ;
Kelley, KW ;
Dantzer, R .
NEUROREPORT, 1996, 7 (15-17) :2823-2827
[4]
BLUTHE RM, 1991, NEUROSCI RES COMMUN, V9, P151
[5]
BONNAFOUS C, 1995, THESIS
[6]
BRANCHEREAU P, 1992, J PHARMACOL EXP THER, V260, P1433
[7]
LIPOPOLYSACCHARIDE AND INTERLEUKIN-1 DEPRESS FOOD-MOTIVATED BEHAVIOR IN MICE BY A VAGAL-MEDIATED MECHANISM [J].
BRETDIBAT, JL ;
BLUTHE, RM ;
KENT, S ;
KELLEY, KW ;
DANTZER, R .
BRAIN BEHAVIOR AND IMMUNITY, 1995, 9 (03) :242-246
[9]
CHANG RSL, 1989, MOL PHARMACOL, V35, P803
[10]
CHANG RSL, 1986, MOL PHARMACOL, V30, P212